Chemical Market Reporter - Neopharm Inc. (Active Pharmaceutical Ingredient Watc
Posted on Monday, June 03 @ 07:00:00 CDT by admin
June 3, 2002 -- NEOPHARM Inc. released positive results on a Phase I clinical trial for SS1 (dsFv)-PE38 which uses the monoclonal antibody SSl (dsFv) to target receptors ...
Click Here to read the entire article...
|
| |
|